L. Fernández-Lopez

Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019

S. Khader, G. Domínguez-Cherit, J. Choreño-Parra, 2021, The Journal of infectious diseases.

Expression of Surfactant protein D (SP-D) distinguishes severe pandemic influenza A(H1N1) from COVID-19

Reyna, S. Khader, G. Domínguez-Cherit, 2021 .

Surface adhesion and host response as pathogenicity factors of Neisseria meningitidis

J. Uberos, M. Molina-Oya, Sylvia Martínez-Serrano, 2015 .

The immune landscape in tuberculosis reveals populations linked to disease and latency.

Maxim N. Artyomov, Laura L. Arthur, A. Swain, 2020, Cell host & microbe.

A unique immune signature of serum cytokine and chemokine dynamics in patients with Zika virus infection from a tropical region in Southern Mexico

G. Ruiz-Palacios, J. Beigel, S. Hunsberger, 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Phenotype of Peripheral NK Cells in Latent, Active, and Meningeal Tuberculosis

S. Khader, J. Choreño-Parra, J. Zúñiga, 2021, Journal of immunology research.

CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome

A. Zlotnik, S. Khader, J. Choreño-Parra, 2021, Frontiers in Immunology.

CXCL17 is a Prognostic Biomarker That Distinguishes Severe Pandemic InfluenzaA(H1N1) from COVID-19

A. Zlotnik, S. Khader, J. Choreño-Parra, 2020 .

Expression of Surfactant protein D (SP-D) distinguishes severe pandemic influenza A(H1N1) from COVID-19

S. Khader, J. Choreño-Parra, J. Zúñiga, 2021 .